These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Fractalkine has anti-apoptotic and proliferative effects on human vascular smooth muscle cells via epidermal growth factor receptor signalling. White GE; Tan TC; John AE; Whatling C; McPheat WL; Greaves DR Cardiovasc Res; 2010 Mar; 85(4):825-35. PubMed ID: 19840952 [TBL] [Abstract][Full Text] [Related]
32. Intermittent hypoxia induces the proliferation of rat vascular smooth muscle cell with the increases in epidermal growth factor family and erbB2 receptor. Kyotani Y; Ota H; Itaya-Hironaka A; Yamauchi A; Sakuramoto-Tsuchida S; Zhao J; Ozawa K; Nagayama K; Ito S; Takasawa S; Kimura H; Uno M; Yoshizumi M Exp Cell Res; 2013 Nov; 319(19):3042-50. PubMed ID: 23968588 [TBL] [Abstract][Full Text] [Related]
33. The role of lysophosphatidic acid receptors in phenotypic modulation of vascular smooth muscle cells. Zhou Z; Niu J; Zhang Z Mol Biol Rep; 2010 Jul; 37(6):2675-86. PubMed ID: 19757175 [TBL] [Abstract][Full Text] [Related]
34. Epidermal growth factor and platelet-derived growth factor-BB induce a stable increase in the activity of low density lipoprotein receptor-related protein in vascular smooth muscle cells by altering receptor distribution and recycling. Weaver AM; McCabe M; Kim I; Allietta MM; Gonias SL J Biol Chem; 1996 Oct; 271(40):24894-900. PubMed ID: 8798766 [TBL] [Abstract][Full Text] [Related]